MSC-NTF cells transplantation (IM)
MSC-NTF-001-HMO-CTIL
Phase 2 mab completed
Quick answer
MSC-NTF cells transplantation (IM) for Amyotrophic Lateral Sclerosis is a Phase 2 program (mab) at BRAINSTORM CELL THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRAINSTORM CELL THERAPEUTICS INC.
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed